1. Home
  2. IMNM vs NG Comparison

IMNM vs NG Comparison

Compare IMNM & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$18.76

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Novagold Resources Inc.

NG

Novagold Resources Inc.

N/A

Current Price

$5.66

Market Cap

2.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNM
NG
Founded
2006
1984
Country
United States
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
IMNM
NG
Price
$18.76
$5.66
Analyst Decision
Strong Buy
Buy
Analyst Count
17
7
Target Price
★ $35.13
$13.13
AVG Volume (30 Days)
1.4M
★ 4.1M
Earning Date
11-09-2026
10-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.40
N/A
EPS
N/A
★ N/A
Revenue
★ $6,941,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$16.41
$5.08
52 Week High
$30.06
$14.40

Technical Indicators

Market Signals
Indicator
IMNM
NG
Relative Strength Index (RSI) 46.46 38.51
Support Level $17.18 $5.08
Resistance Level $23.30 $6.69
Average True Range (ATR) 1.39 0.38
MACD 0.20 -0.01
Stochastic Oscillator 25.98 4.51

Price Performance

Historical Comparison
IMNM
NG

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About NG Novagold Resources Inc.

Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other precious metals.

Share on Social Networks: